Market Newsdesk

NEW YORK and NEW ORLEANS, Aug. 04, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NasdaqGS: CAPR) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of California.

Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nasdaqgs-capr/  

Capricor investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-capr/ to learn more.

>>>

CLICK HERE

for more information

CASE DETAILS: According to the Complaint, Capricor and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On July 27, 2026, pre-market, the U.S. Food and Drug Administration (“FDA”) published briefing documents ahead of its July 29 advisory committee meeting to review the Biologics License Application (“BLA”) for the Company’s lead product candidate, Deramiocel, finding that the Company made changes to the pre-specified statistical analysis plan (“SAP”) and that the final version “was not submitted to FDA for review prior to BLA submission and was not discussed and consequently not agreed upon.” Importantly, the final SAP was finalized just one day before the data was unblinded. The FDA disagreed with the changes made to the SAP, explaining that converting raw change to percent change and back again added unnecessary complexity and undermined accuracy, without scientific justification for doing so. As a result, the FDA stated that it “considers [Capricor’s] analyses based on the post-study SAP versions to be post-hoc and exploratory.” According to the briefing documents, the benefit-risk profile for deramiocel looked unfavorable given the lack of evidence supporting its effectiveness.

On this news, Capricor’s stock fell $12.70, or 64%, to close at $7.00 per share on July 27, 2026, on unusually heavy trading volume

The case is Nkamga v. Capricor Therapeutics, Inc., et al., No. 3:26-cv-04385.

WHAT TO DO? If you invested in Capricor and suffered a loss during the relevant time frame, you have until September 28, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

>>>To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click

HERE

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

NEW YORK and NEW ORLEANS, Aug. 04, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. (“Erasca” or the “Company”) (NasdaqGS: ERAS) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Erasca, Inc. who were adversely affected if they purchased the Company’s shares between January 14, 2025 and April 26, 2026, both dates inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of California.

Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nasdaqgs-eras/

Erasca investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-eras/ to learn more.

CLICK HERE

for more information

CASE DETAILS: According to the Complaint, Erasca and certain of its executives are charged with failing to disclose material information during the class period, violating federal securities laws.

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the preclinical data for the Company’s ERAS-0015 product, a pan-RAS molecular glue for the treatment of patients with RAS-mutated solid tumors, was based on improper comparisons to Revolution Medicines, Inc. and placed Erasca at risk of violating patent and trade secret protections; and (ii) based on the foregoing, the defendants lacked a reasonable basis for their positive statements related to ERAS-0015.

The case is Cheng v. Erasca, Inc., No. 26-cv-03481.

WHAT TO DO? If you invested in Erasca and suffered a loss during the relevant time frame, you have until August 10, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

NEW YORK and NEW ORLEANS, Aug. 04, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in ADMA Biologics, Inc. (“ADMA” or the “Company”) (NasdaqGM: ADMA) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of ADMA Biologics, Inc. who were adversely affected if they purchased the Company’s securities between August 9, 2024 and March 25, 2026, both dates inclusive (the “Class Period”). This action is pending in the United States District Court for the District of New Jersey.

Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nasdaqgm-adma/?prs=globe

ADMA investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgm-adma/?prs=globe to learn more.

CLICK HERE

for more information

CASE DETAILS: According to the Complaint, ADMA Biologics and certain of its executives are charged with failing to disclose material information in the Offering Documents, violating federal securities laws.

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company engaged in an undisclosed related party transaction; (ii) the Company used channel stuffing to create an appearance of revenue; (iii) the Company lacked adequate internal controls; (iv) as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

The case is Mazzarino v. ADMA Biologics, Inc., et al, No. 26-cv-04793.

WHAT TO DO? If you invested in ADMA and suffered a loss during the relevant time frame, you have until August 10, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

NEW YORK and NEW ORLEANS, Aug. 04, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 10, 2026 to file lead plaintiff applications in a securities class action lawsuit against Zillow Group, Inc. (NasdaqGS: ZG, Z) (“Zillow” or the “Company”), if they purchased or otherwise acquired Zillow Class A or Class C common stock between February 11, 2025 and May 7, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Western District of Washington.

What You May Do

If you purchased shares of Zillow as described above and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 11-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-zg-z/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by August 10, 2026.

CLICK

HERE for more information

About the Lawsuit

Zillow and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) Zillow’s agreement with Redfin was not a “partnership,” but rather an acquisition of Redfin’s business; (ii) as a result of the Redfin Agreement, Zillow faced a materially heightened risk of regulatory scrutiny and liability under federal antitrust laws; (iii) upon the filing of an antitrust lawsuit, Zillow continued to downplay its legal exposure; and (iv) as a result, Defendants’ statements about Zillow’s business, operations, and prospects, were materially false and misleading and or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

The case is Breidert v. Zillow Group, Inc., et al., 26-cv-02016.

To Learn More, Click

HERE

About

Kahn Swick & Foti

, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors, in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

For More Information about the case, Click

HERE

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

NEW YORK and NEW ORLEANS, Aug. 04, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 10, 2026 to file lead plaintiff applications in a securities class action lawsuit against Via Transportation, Inc. (“Via” or the “Company”) (NYSE: VIA), if they purchased or otherwise acquired the Company’s shares pursuant to and/or traceable to the Company’s September 2025 initial public offering (the “IPO” or the “Offering”). This action is pending in the United States District Court for the Southern District of New York.

What You May Do

If you purchased shares of Via Transportation as above and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-via/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by August 10, 2026.

>>>

CLICK HERE

for more information

About the Lawsuit

The Complaint alleges that the Registration Statement and Prospectus (filed with the SEC on August 15, 2025, and September 15, 2025, respectively) including all amendments thereto (collectively, the “Offering Documents”), contained materially incorrect or misleading statements and/or omitted material information that was required by law to be disclosed.  

According to the Complaint, at the time of the IPO, and unbeknownst to investors, the Company had already begun to encounter obstacles including that it was adding customers faster than those customers were generating revenue, resulting in a decline in ARR per customer for the first time in eight quarters, and that Germany was stuck in a regulatory transition where customers had adopted microtransit but Via, as it later revealed, could not actually “sell the entire platform.”

By the commencement of the action, Via’s shares traded as low as $14.52, a decline of nearly 70% from the Offering Price.

The case is Garlesky v. Via Transportation, Inc., 26-cv-04870.

>>>To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click

HERE

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

NEW YORK and NEW ORLEANS, Aug. 04, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Avis Budget Group, Inc. (“Avis” or the “Company”) (NasdaqGS: CAR) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Avis securities (including those who bought Avis common stock to cover a short position) between February 20, 2025 and April 21, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Florida.

Follow the link below to get more information and be contacted by a member of our team:

https://www.ksfcounsel.com/cases/nasdaqgs-car/  

Avis investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-car/ to learn more.

>>>

CLICK HERE

for more information

CASE DETAILS: According to the Complaint, Avis and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

According to the complaint, Defendants Pentwater and Halbower engaged in a scheme to manipulate the market for Avis securities. Pentwater, as one of Avis’s largest shareholders — holding an approximate 51% total economic interest in the Company through stock and cash-settled swaps as of March 2026 — allegedly leveraged this position by aggressively purchasing Avis stock during the Class Period. This buying activity triggered unusual volatility and a short squeeze in Avis securities, meaning a rapid surge in the stock price as short sellers bought back shares to cover their losses, which in turn fueled further price increases. The result, according to the complaint, was a significant increase in the value of Pentwater’s Avis holdings.   Avis’s stock price reached a staggering high of $765.94 per share during intraday trading on April 21, an increase of approximately 419% over its $147.52 opening price on April 1, before closing at $713.97 per share. Then, over the following trading sessions, Avis’s share price collapsed by 74.51%, closing at $182.005 per share on April 28, 2026.

The case is Hakimian v. Pentwater Capital Management LP, et al., No. 26-cv-02275.

WHAT TO DO? If you invested in Avis and suffered a loss during the relevant time frame, you have until September 29, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.

>>>To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click

HERE

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

PASCAGOULA, Miss., Aug. 04, 2026 (GLOBE NEWSWIRE) — HII (NYSE: HII) and HD Hyundai Heavy Industries (HHI) are advancing their strategic partnership with a pilot program to implement additional intelligent mechanized welding equipment at HII’s Ingalls Shipbuilding division, expanding Ingalls’ robust existing automation and technology strategy. The pilot is a meaningful step in advancing U.S.-Korea shipbuilding cooperation, as outlined in a 2025 memorandum of understanding (MOU) between the two companies, and underscores HII’s commitment to innovate operations as it delivers ships to the U.S. Navy.

“Ingalls operates one of the most advanced automated production lines in the U.S. shipbuilding industrial base,” Ingalls Shipbuilding President Brian Blanchette said. “Investments in technology and automation range from large-scale automated panel lines and material handling, to robotic bulkhead fabrication, to numerous other digital and advanced manufacturing tools. This pilot extends that automation footprint further into the production process, and to a greater share of the workforce. Working with HHI allows us to expand targeted automation functions, and integrate shared best practices as we continue delivering the most capable ships to the U.S. Navy.”

Photos accompanying this release are available at: http://hii.com/news/hii-expands-welding-automation-at-ingalls-shipbuilding-through-partnership-with-hd-hhi/.

The pilot deploys intelligent mechanized welding systems in unit-fabrication areas that currently rely predominantly on manual welding. These systems are designed to make welding, one of the most demanding processes in shipbuilding, safer and more efficient. The system automatically recognizes workpieces and welding conditions, corrects welding positions in real time and captures process data that can support quality control, process improvement and traceability. Ingalls has ensured the machines comply with existing U.S. Navy fabrication standards and will use the pilot to identify opportunities for improved efficiency.

“This pilot program reflects the strengthening of our partnership and the advantages of open technical collaboration,” said Dr. Won-ho Joo, chief executive of the Naval & Special Ship Business Unit at HHI. “We look forward to working with HII to enhance shipbuilding efficiency and deliver greater value to our customers.”

The intelligent mechanized welding pilot grew out of a three-day technical exchange at Ingalls where the companies evaluated shipbuilding technologies and automation opportunities across their respective shipyards. During the visit, Ingalls showcased its hybrid laser welding process, robotics integration, and facility layout designed to support streamlined construction.

Additional automation and technology initiatives under evaluation or in implementation at HII’s shipyards, Ingalls Shipbuilding in Mississippi and Newport News Shipbuilding in Virginia, include new robotic and cobot applications including fabrication cells, additive manufacturing, automated steel processing systems, integrated production control software that supports precise construction and real-time production insights, and continuous upgrades to automated panel and bulkhead lines. Additionally, HII’s recently announced High-Yield Production Robotics (HYPR) initiative teams the company with emerging physical AI technology companies to implement AI-enabled tools aimed at augmenting the capabilities of the existing shipbuilding workforce.

About HII

HII is America’s largest shipbuilder, delivering the world’s most powerful ships and all-domain mission technologies, including unmanned systems, to U.S. and allied defense customers. HII is the largest producer of unmanned underwater vehicles for the U.S. Navy and the world.

With a more than 140-year history of advancing U.S. national security, HII builds and integrates defense capabilities extending from the core fleet to C6ISR, AI/ML, EW and synthetic training. Headquartered in Virginia, HII’s workforce is 45,000 strong. For more information, visit:

• HII on the web: https://www.HII.com/
• HII on Facebook: https://www.facebook.com/TeamHII
• HII on X: https://www.twitter.com/WeAreHII
• HII on Instagram: https://www.instagram.com/WeAreHII
• HII on LinkedIn: https://www.linkedin.com/company/wearehii

Contact:

Kimberly K. Aguillard
[email protected]
228-355-5663

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2c51fda4-a8a3-4bb7-a6de-cb116d4912e6

NEW YORK and NEW ORLEANS, Aug. 04, 2026 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation (“Procept” or the “Company”) (NasdaqGM: PRCT), if they purchased the Company’s shares between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

What You May Do

If you purchased shares of Procept and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3616 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgm-prct/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by September 22, 2026.

>>>

CLICK HERE

for more information

About the Lawsuit

Procept and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On February 25, 2026, the Company announced earnings results for its fourth fiscal quarter and year ending December 31, 2025, disclosing that, contrary to prior assurances that U.S. handpiece sales were largely commensurate with procedures, handpiece sales had in fact materially exceeded procedures in every quarter since the first fiscal quarter of 2023, a differential which had consistently grown over time, ultimately resulting in cumulative excess field inventory of more than 10,000 units. Due to this inventory glut, the Company revealed that quarterly handpiece unit sales in the U.S. had declined significantly from 13,225 units in the third quarter to 9,400 units, representing a sequential decline of nearly 30%, resulting in the Company widely missing its annual revenue guidance by tens of millions of dollars.

On this news, the price of Procept shares fell from $27.84 per share on February 25, 2026 to $22.69 per share on February 27, 2026, a decline of more than 18% over a two-day trading period, on above-average trading volume.

The case is Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics Corporation, No. 26-cv-07691.

>>>To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click

HERE

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-833-538-3616
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn